Assessment of Cancer-Associated Cachexia - How to Approach Physical Function Evaluation

被引:5
作者
Fram, Julia [1 ,2 ]
Vail, Caroline [1 ,2 ]
Roy, Ishan [1 ,2 ,3 ]
机构
[1] Shirley Ryan AbilityLab, 26th Floor,355 E Erie St, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Phys Med Sr Rehabil, 710 N Lake Shore Dr 1022, Chicago, IL 60611 USA
[3] Robert H Lurie Canc Ctr, 675 N St Clair St Fl 21 Ste 100, Chicago, IL 60611 USA
关键词
Cancer; Cachexia; Rehabilitation; Physical function; QUALITY-OF-LIFE; INSTRUMENTAL ACTIVITIES; DIAGNOSTIC-CRITERIA; PERFORMANCE STATUS; CLINICAL-TRIALS; CARE; REHABILITATION; TOOL; SURVIVORS; ANOREXIA;
D O I
10.1007/s11912-022-01258-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Cachexia is a devastating syndrome that impacts a majority of cancer patients. Early assessment of cachexia is critical to implementing cachexia treatments. Our aim was to summarize the existing cachexia assessment tools for their utility in both symptom and function evaluation. Recent Findings Several tools now exist that provide a symptom-based approach for evaluating weight change, appetite, and nutrition impact symptoms in cancer patients with cachexia. However, current instruments used to assess physical function changes related to cachexia are limited in depth and breadth. Instead, we recommend a tiered approach to cachexia-related functional assessment that involves evaluation of activities of daily living, general mobility, and exercise tolerance in a prioritized sequence. Current tools for cancer-associated cachexia assessment are adept at symptom evaluation. New approaches to physical function evaluation are needed that efficiently and broadly evaluate the diverse functional needs of cachexia patients.
引用
收藏
页码:751 / 761
页数:11
相关论文
共 101 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Eating-related distress in advanced cancer patients with cachexia and family members: a survey in palliative and supportive care settings [J].
Amano, Koji ;
Morita, Tatsuya ;
Koshimoto, Saori ;
Uno, Teruaki ;
Katayama, Hirofumi ;
Tatara, Ryohei .
SUPPORTIVE CARE IN CANCER, 2019, 27 (08) :2869-2876
[3]  
Andrews JS., 2021, J GERONTOL SER, VXX, P1
[4]  
[Anonymous], 1995, Bull World Health Organ, V73, P135
[5]   Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines [J].
Arends, J. ;
Strasser, F. ;
Gonella, S. ;
Solheim, T. S. ;
Madeddu, C. ;
Ravasco, P. ;
Buonaccorso, L. ;
de van der Schueren, M. A. E. ;
Baldwin, C. ;
Chasen, M. ;
Ripamonti, C., I .
ESMO OPEN, 2021, 6 (03)
[6]   The cachexia score (CASCO): a new tool for staging cachectic cancer patients [J].
Argiles, Josep M. ;
Lopez-Soriano, Francisco J. ;
Toledo, Miriam ;
Betancourt, Angelica ;
Serpe, Roberto ;
Busquets, Silvia .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2011, 2 (02) :87-93
[7]   Cancer-associated cachexia [J].
Baracos, Vickie E. ;
Martin, Lisa ;
Korc, Murray ;
Guttridge, Denis C. ;
Fearon, Kenneth C. H. .
NATURE REVIEWS DISEASE PRIMERS, 2018, 4
[8]   An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer [J].
Barker, Tyler ;
Fulde, Gail ;
Moulton, Bryce ;
Nadauld, Lincoln D. ;
Rhodes, Terence .
SCIENTIFIC REPORTS, 2020, 10 (01)
[9]  
Bennani-Baiti N, 2009, J ROY COLL PHYS EDIN, V39, P257
[10]  
BHAKTA A, 2021, PM&R